Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trial

Not Applicable

Completed

• Conditions: the efficacy of triamcinolone and bevacizumabwas measured in patients with Central Retinal Vein Occlusion; Retinal Vein Occlusion, Triamcinolone; Bevacizumab, Intravitreal Injections&#44

• Registration Number: TCTR20170612005
• Lead Sponsor: rmia university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-07-14
• Study Start: 2017-06-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

patients with CRVO and satisfaction to participate in the study

Exclusion Criteria

use of macular photocoagulation and intravitreal injection of any drug .

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
recovery of patients with Central Retinal Vein Occlusion 3 months visual asscessment

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A